A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Clinical trial NCT05001282 · TERMINATED

Trial details

NCT number: NCT05001282
Sponsor: Elucida Oncology
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Ovarian Neoplasms Ovarian Carcinoma Endometrial Cancer Ovary Cancer Ovary Neoplasm Ovary Disease Ovary Metastasis Ovarian Diseases Ovarian Cancer Stage Ovarian Epithelial Cancer Ovarian Adenocarcinoma

Start date: 2021-09-13
Primary completion: 2024-06-07
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.